Only HSA–CML led to a significant response with a significant upregulation of IL-1β (7-fold) and IL-8 (5-fold), and an increased trend for TNFα was measured (Figure 6). The gene discussed is TNF; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.